Antipsychotic Medications: Adherence and Availability in East Jerusalem

Simple item page
dc.contributor.authorFatima Hamad
dc.contributor.authorRahaf Jubeh
dc.contributor.authorMaysa Nabulsi
dc.date.accessioned2022-06-25T05:35:59Z
dc.date.available2022-06-25T05:35:59Z
dc.date.issued2022-05-11
dc.description.abstractBackground: Schizophrenia is a severe illness affecting all life aspects of the patients including work, self-care and capacity to establish interpersonal relationships. It is known to affect about 1.0% of the population. Despite the fact that adherence to antipsychotic medications is the cornerstone in the treatment and prevention of relapse of the disease, non-adherence is a major problem among schizophrenia patients.
dc.identifier.urihttps://hdl.handle.net/20.500.12213/6601
dc.language.isoen
dc.publisherAl-Quds University, Deanship of Scientific Research
dc.titleAntipsychotic Medications: Adherence and Availability in East Jerusalem
dc.typeArticle
dspace.entity.type
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Antipsychotic Medications Adherence and Availability in East Jerusalem.pdf
Size:
324.49 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.61 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Pharmacy and Dentistry